Canopy Biosciences Enters Bioprocessing Market with Launch of Host Cell Protein Detection Kits
Canopy Biosciences signs deal with Array Bridge to market kits for impurity analysis ST. LOUIS, July 13, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it will enter the bioprocessing field by marketing kits for host cell protein detection. Array Bridge, a biotech company that developed the... Read more